Longevity Health
(OTC) XAGE
Longevity Health Financials at a Glance
Market Cap
$698,400
Revenue (TTM)
$1.46M
Net Income (TTM)
$5.74M
EPS (TTM)
$-5.08
P/E Ratio
-0.08
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.39
Volume
4,620
Open
$0.39
Price
$0.39
Volume
4,620
Open
$0.39
Previous Close
$0.39
Daily Range
$0.39 - $0.39
52-Week Range
$0.25 - $9.31
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.39
Volume
4,620
Open
$0.39
Previous Close
$0.39
Daily Range
$0.39 - $0.39
52-Week Range
$0.25 - $9.31
XAGE News
XAGE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Longevity Health
Industry
Biotechnology
Sector
Health CareEmployees
15
CEO
Rajiv Sarman Shukla
Website
www.carmellcosmetics.comHeadquarters
Pittsburgh, PA 15203, US
XAGE Financials
Key Financial Metrics (TTM)
Gross Margin
55%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-106%
Return on Capital
2%
Return on Assets
-2%
Earnings Yield
-12.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$698.40K
Shares Outstanding
1.78M
Volume
4.62K
Short Interest
0.00%
Avg. Volume
2.26K
Financials (TTM)
Gross Profit
$43.96K
Operating Income
$5.00M
EBITDA
$10.50M
Operating Cash Flow
$4.39M
Capital Expenditure
$0.00
Free Cash Flow
$4.39M
Cash & ST Invst.
$157.14K
Total Debt
$638.99K
Longevity Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$425.86K
+1975.5%
Gross Profit
$207.38K
+1222.7%
Gross Margin
48.70%
N/A
Market Cap
$698.40K
N/A
Market Cap/Employee
$46.56K
N/A
Employees
15
N/A
Net Income
$1.43M
+50.3%
EBITDA
$1.50M
+46.9%
Quarterly Fundamentals
Net Cash
$490.60K
+38.0%
Accounts Receivable
$46.52K
-78.8%
Inventory
$1.01M
+935.2%
Long Term Debt
$239.26K
-28.1%
Short Term Debt
$379.37K
-15.5%
Return on Assets
-1.74%
N/A
Return on Invested Capital
1.65%
N/A
Free Cash Flow
$1.45M
-3.2%
Operating Cash Flow
$1.43M
-2.2%